Zwitterionic Compositions and Method as Biological Response Modifiers
A method of treating a disease in a mammal by administrating a therapeutic effective amount of an amphoteric zwitterion compound as an active ingredient. A pharmaceutical composition which comprises an amphoteric zwitterionic compound as an active ingredient in combination with a carrier and other adjunctive pharmaceutical agents.